SUBSCRIBE
SUBSCRIBE
News   FDA

Europe Approves Wyeth’s Enbrel for Psoriasis in Children

January 8, 2009 | 
1 min read
LONDON, Jan 8 (Reuters) - Wyeth's established drug Enbrel has been approved by the European Commission as the first biologic treatment for children with severe plaque psoriasis, the U.S. company said on Thursday.
FDA Approvals Europe
MORE ON THIS TOPIC
Podcast
Modernagate Fallout, Disc’s Rejection, Compass’ Psilocybin Data, CDC’s Lost Leaders
February 18, 2026
 · 
1 min read
 · 
Heather McKenzie
illustration of doubtful man thinks whether to jump to the other side of the mountain, dilemma concept
Rare disease
Disc’s Regulatory Comeback Plan for Rejected Drug Relies on Old FDA Leadership
February 17, 2026
 · 
3 min read
 · 
Annalee Armstrong
Podcast
As FDA Moves Away From Animal Testing, AI and Organoids Can Shine
February 17, 2026
 · 
1 min read
 · 
Jef Akst
stethoscope on glass globe - Usa
FDA
Moderna’s mRNA Vaccine Refusal Comes Amid Global Advanced Therapies Push
February 17, 2026
 · 
5 min read
 · 
Heather McKenzie